Expanded Access: Approved for Marketing
"""Expanded access: approved for marketing"" is when the intervention has been approved by the U.S. Food and Drug Administration for use by the public. (CTG) """
"""Expanded access: approved for marketing"" is when the intervention has been approved by the U.S. Food and Drug Administration for use by the public. (CTG) """
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
